Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,803 Publications201,348 Funding7,268 Clinical research1

FiltersClear all

Status

Completed1

Study type

Interventional1

Phase

Phase 21

Investigator

Grant Ellsworth1

Department

Medicine1

Condition

HIV Seropositivity1
Squamous Intraepithelial Lesions1

Intervention type

Device1
Drug21
Other14
Procedure14
Biological8
Radiation6

Sponsor type

Cooperative group1
Industry139
WCM (investigator-initiated)31
Other academic18
NIH1

Start date

to

Has results posted1

Device×Cooperative group×Clear all

Showing 1–1 of 1 studySort:

CompletedInterventional · Phase 2NCT03603808 ↗
A Phase 2 Evaluation of VGX-3100, a Synthetic DNA Immunotherapy Targeting Human Papillomavirus 16 and 18 E6 and E7 Proteins, for Anal High-Grade Squamous Intraepithelial Lesions (HSIL) in HIV-Positive Individuals

Dietary supplement2

Grant EllsworthPI

Intervention: Device: Electroporation · Biological: HPV DNA Plasmids Therapeutic Vaccine VGX-3100 · Other: Laboratory Biomarker Analysis
Dates: Sep 2018 – Dec 2024· Results posted
Sponsor: AIDS Malignancy Consortium

Anal Intraepithelial NeoplasiaHigh Grade Squamous Intraepithelial NeoplasiaHIV Positivity+2 more